Explore the options in hematology and oncology. The 2019 Debates and Didactics in Hematology and Oncology conference will feature a comprehensive review of treatments for patients with cancer or blood disorders. Expert faculty and thought leaders from across the nation will engage in interactive debates and didactic lectures on controversial topics and standards of care, offering you the opportunity to hear how science supports each point of view. Presentations and discussions will focus on current research, including the use of molecular targeted therapy, immunotherapies, and other novel therapeutic approaches.
This educational activity is intended for hematologists, oncologists, and other allied healthcare professionals interested in the management of hematologic and oncologic malignancies.
After successful completion of this educational activity, participants should be able to:
- Evaluate the risks and benefits of emerging therapies and novel treatment strategies for patients with solid tumors and hematologic malignancies, as well as the practical utility of these approaches based on recent clinical data
- Apply best practices regarding the treatment of patients with cancer, including integration of novel therapeutic approaches and individualization of care
- Appropriately integrate multimodality therapy and multidisciplinary care to improve the management of patients with cancer
- Before May 6: $550
- On or After May 6: $650
- Midlevel Provider/Nurse
- Before May 6: $300
- On or After May 6: $375
- Fellows, Residents, Students
- Before May 6: $50
- On or After May 6: $75
- Pharmaceutical Industry Representative (Nonexhibitor)
- Before May 6: $1250
- On or After May 6: $1500
||Before May 6
||On or After May 6
|Fellows, Residents, Students
|Pharmaceutical Industry Representative (Nonexhibitor)
50% of the registration fee is refundable through May 31, 2019. Substitutions will be accepted up to one week prior to the meeting date with written notice.
Cancellation Fee Hotel Rooms
Cancellations between June 6 (the hotel cut-off date) and July 15 will only be refunded if the room can be resold. No hotel room fees will be refunded after July 15, 2019.
prIME Oncology does not accept responsibility for reimbursement of travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
This activity is provided by Winship Cancer Institute of Emory University.
Options are available to organizations interested in supporting this conference. For more information, please contact us.
prIME Oncology complies with all Sunshine Act reporting requirements as outlined by CMS and applicable manufacturers and with EFPIA Disclosure Code reporting requirements.
Disclosure of Relevant Financial Relationships
prIME Oncology assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.
Disclosure Regarding Unlabeled Use
This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.